JockGood question - yes I do believe or lets say hope that the...

Jock
Good question - yes I do believe or lets say hope that the share price will be higher then what it is now.
However there are still a number of risks out there so my expectations are much lower then most on here.
So what are those risks.
First risk to overcome would be funding so how this is solved will have a big bearing on the sp
The second risk would be approval of ODD application - if approved then I would expect the sp to be around 80 cents
Third risk would be the ongoing outcomes of the extension trial if all patients remain alive with slowed disease progression if so then the sp should be around $1
A further risk would be recruitment of patients for the phase 2 trial and out come of that trial, if recruitment goes well then the sp might go to $1.10 and if the data comes out well then I wouldn't put a sp

So in 6 months I expect the sp to be somewhere between 60 cents and 90 cents as I see a problem with recruitment
Now let's say the ODD gets rejected then I would say the sp drops back to around the 10 cents mark